AGT and hypertensive disorder: Evidence suggests that angiotensinogen is a more potent influencer of blood pressure than previously suspected [35, 39], often more influential than other components of RAAS [40], and deserves more attention as a potential target in hypertension-related therapies [35], proposals that are supported by our findings.